These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
476 related articles for article (PubMed ID: 20884620)
1. p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease. Wu IW; Hsu KH; Lee CC; Sun CY; Hsu HJ; Tsai CJ; Tzen CY; Wang YC; Lin CY; Wu MS Nephrol Dial Transplant; 2011 Mar; 26(3):938-47. PubMed ID: 20884620 [TBL] [Abstract][Full Text] [Related]
2. Evolution of protein-bound uremic toxins indoxyl sulphate and p-cresyl sulphate in acute kidney injury. Veldeman L; Vanmassenhove J; Van Biesen W; Massy ZA; Liabeuf S; Glorieux G; Vanholder R Int Urol Nephrol; 2019 Feb; 51(2):293-302. PubMed ID: 30604232 [TBL] [Abstract][Full Text] [Related]
3. Uraemic toxins and cardiovascular disease across the chronic kidney disease spectrum: an observational study. Rossi M; Campbell K; Johnson D; Stanton T; Pascoe E; Hawley C; Dimeski G; McWhinney B; Ungerer J; Isbel N Nutr Metab Cardiovasc Dis; 2014 Sep; 24(9):1035-42. PubMed ID: 24880738 [TBL] [Abstract][Full Text] [Related]
4. Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure. Lin CJ; Wu V; Wu PC; Wu CJ PLoS One; 2015; 10(7):e0132589. PubMed ID: 26173073 [TBL] [Abstract][Full Text] [Related]
5. Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients--a prospective cohort study. Wu IW; Hsu KH; Hsu HJ; Lee CC; Sun CY; Tsai CJ; Wu MS Nephrol Dial Transplant; 2012 Mar; 27(3):1169-75. PubMed ID: 21891772 [TBL] [Abstract][Full Text] [Related]
6. p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients. Meijers BK; De Loor H; Bammens B; Verbeke K; Vanrenterghem Y; Evenepoel P Clin J Am Soc Nephrol; 2009 Dec; 4(12):1932-8. PubMed ID: 19833905 [TBL] [Abstract][Full Text] [Related]
7. Uremic toxin development in living kidney donors: a longitudinal study. Rossi M; Campbell KL; Johnson DW; Stanton T; Haluska BA; Hawley CM; Dimeski G; McWhinney BC; Ungerer JP; Kaisar OM; Isbel NM Transplantation; 2014 Mar; 97(5):548-54. PubMed ID: 24162249 [TBL] [Abstract][Full Text] [Related]
11. Serum concentrations of p-cresyl sulfate and indoxyl sulfate, but not inflammatory markers, increase in incident peritoneal dialysis patients in parallel with loss of residual renal function. Viaene L; Meijers BK; Bammens B; Vanrenterghem Y; Evenepoel P Perit Dial Int; 2014; 34(1):71-8. PubMed ID: 24179107 [TBL] [Abstract][Full Text] [Related]
12. Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor. Madero M; Cano KB; Campos I; Tao X; Maheshwari V; Brown J; Cornejo B; Handelman G; Thijssen S; Kotanko P Clin J Am Soc Nephrol; 2019 Mar; 14(3):394-402. PubMed ID: 30755453 [TBL] [Abstract][Full Text] [Related]
13. The Role of Liver in Determining Serum Colon-Derived Uremic Solutes. Lin CJ; Liou TC; Pan CF; Wu PC; Sun FJ; Liu HL; Chen HH; Wu CJ PLoS One; 2015; 10(8):e0134590. PubMed ID: 26258409 [TBL] [Abstract][Full Text] [Related]
14. Renal clearance and intestinal generation of p-cresyl sulfate and indoxyl sulfate in CKD. Poesen R; Viaene L; Verbeke K; Claes K; Bammens B; Sprangers B; Naesens M; Vanrenterghem Y; Kuypers D; Evenepoel P; Meijers B Clin J Am Soc Nephrol; 2013 Sep; 8(9):1508-14. PubMed ID: 23813557 [TBL] [Abstract][Full Text] [Related]
15. Removal of protein-bound uraemic toxins by haemodialysis. Niwa T Blood Purif; 2013; 35 Suppl 2():20-5. PubMed ID: 23676831 [TBL] [Abstract][Full Text] [Related]
16. Shen-Shuai-Ning granule decreased serum concentrations of indoxyl sulphate in uremic patients undergoing peritoneal dialysis. Chen X; Gao S; Ruan M; Chen S; Xu J; Xing X; Pan X; Mei C; Mao Z Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 29921575 [TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal-related uremic toxins in peritoneal dialysis: a pilot study with a 5-year follow-up. Lin CJ; Pan CF; Chuang CK; Liu HL; Sun FJ; Wang TJ; Chen HH; Wu CJ Arch Med Res; 2013 Oct; 44(7):535-41. PubMed ID: 24055267 [TBL] [Abstract][Full Text] [Related]
18. Microbiome perturbation by oral vancomycin reduces plasma concentration of two gut-derived uremic solutes, indoxyl sulfate and p-cresyl sulfate, in end-stage renal disease. Nazzal L; Roberts J; Singh P; Jhawar S; Matalon A; Gao Z; Holzman R; Liebes L; Blaser MJ; Lowenstein J Nephrol Dial Transplant; 2017 Nov; 32(11):1809-1817. PubMed ID: 28379433 [TBL] [Abstract][Full Text] [Related]
19. Increased levels of total P-Cresylsulphate and indoxyl sulphate are associated with coronary artery disease in patients with diabetic nephropathy. Chiu CA; Lu LF; Yu TH; Hung WC; Chung FM; Tsai IT; Yang CY; Hsu CC; Lu YC; Wang CP; Lee YJ Rev Diabet Stud; 2010; 7(4):275-84. PubMed ID: 21713315 [TBL] [Abstract][Full Text] [Related]